STEPHEN DOUGLAS RUBIN
Medical Practice in Southampton, NJ
License number
Pennsylvania MD034245E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Southampton, NJ 08088
Pennsylvania
Pennsylvania
Personal information
See more information about STEPHEN DOUGLAS RUBIN at radaris.comName
Address
Phone
1000 Earls Ct, Lititz, PA 17543
4 W View Dr, Flemington, NJ 08822
462 Ashford Dr, Lancaster, PA 17601
335 Cherry Ln, Wynnewood, PA 19096
31 Waxwood Rd, Shoemakersvle, PA 19555
Professional information
See more information about STEPHEN DOUGLAS RUBIN at trustoria.com
Composition Comprising A Combination Of An Aromatase Inhibitor, A Progestin And An Oestrogen And Its Use For The Treatment Of Endometriosis
Composition Comprising A Combination Of An Aromatase Inhibitor, A Progestin And An Oestrogen And Its Use For The Treatment Of Endometriosis
US Patent:
2011000, Jan 13, 2011
Filed:
Sep 20, 2010
Appl. No.:
12/886269
Inventors:
Stephen Rubin - Southampton NJ, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/56, A61K 31/5685, A61P 35/00, A61K 31/57, A61K 31/566
US Classification:
514170
Abstract:
The invention relates to a method of treating endometriosis using a combination of an aromatase inhibitor, a progestin and an oestrogen. The invention also relates to pharmaceutical formulations comprising said combination.
Composition Comprising A Combination Of An Aromatase Inhibitor, A Progestin And An Oestrogen And Its Use For The Treatment Of Endometriosis
Composition Comprising A Combination Of An Aromatase Inhibitor, A Progestin And An Oestrogen And Its Use For The Treatment Of Endometriosis
US Patent:
7910570, Mar 22, 2011
Filed:
Feb 3, 2004
Appl. No.:
10/543584
Inventors:
Stephen Rubin - Southampton NJ, US
Serdar E. Bulun - Chicago IL, US
Serdar E. Bulun - Chicago IL, US
Assignee:
AstraZeneca AB - Sodertalje
International Classification:
A01N 45/00, A61K 31/56
US Classification:
514170, 514171, 514178, 514182, 514899
Abstract:
The invention relates to a method of treating endometriosis using a combination of an aromatase inhibitor, a progestin and an oestrogen. The invention also relates to pharmaceutical formulations comprising said combination.